Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Dual Immune Modulatory Effect of Vitamin A in Human Visceral Leishmaniasis

  • Bruna L. Lima Maciel,

    Affiliations Department of Nutrition, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil, Department of Biochemistry, Bioscience Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil, Institute of Tropical Medicine of Rio Grande do Norte, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil

    ⨯
  • Joanna Gardel Valverde,

    Affiliation Department of Biochemistry, Bioscience Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil

    ⨯
  • João Firmino Rodrigues-Neto,

    Affiliation Department of Biochemistry, Bioscience Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil

    ⨯
  • Francisco Freire-Neto,

    Affiliations Department of Biochemistry, Bioscience Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil, Institute of Tropical Medicine of Rio Grande do Norte, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil

    ⨯
  • Tatjana S. L. Keesen,

    Affiliation Department of Biochemistry, Bioscience Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil

    ⨯
  • Selma Maria Bezerra Jeronimo

    smbj@cb.ufrn.br

    Affiliations Department of Biochemistry, Bioscience Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil, Institute of Tropical Medicine of Rio Grande do Norte, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil, National Institute of Science and Technology of Tropical Diseases (INCT-DT), Salvador, BA, Brazil

    ⨯

Correction

1 Dec 2014: The PLOS ONE Staff (2014) Correction: Dual Immune Modulatory Effect of Vitamin A in Human Visceral Leishmaniasis. PLOS ONE 9(12): e115080. https://doi.org/10.1371/journal.pone.0115080 View correction

Abstract

Vitamin A supplementation has shown to prevent mortality by diarrheal and respiratory diseases in several countries. Nevertheless, there are few studies investigating the effect of vitamin A in visceral leishmaniasis (VL), although there are reports of its deficiency in children with symptomatic VL in Brazil and Bangladesh. This study analyzed the effect of vitamin A on a subset of Treg cells and monocytes isolated from symptomatic VL and from healthy children residing in an endemic area for VL in Northeast Brazil. Serum retinol concentrations correlated inversely with IL-10 and TGF-β productions in CD4+CD25highFoxp3+ T cells isolated from children with VL stimulated with leishmanial antigens. All-trans retinoic acid in vitro induced IL-10 in CD4+CD25highFoxp3+ T cells; IL-10 and TGF-β production in CD4+CD25−Foxp3− T cells, and IL-10 in monocytes isolated from healthy children. However, the use of all-trans retinoic acid together with leishmanial antigens in vitro prevented increases in IL-10 production in Treg cells and monocytes isolated from VL children. Strikingly, those results show a potential dual role of vitamin A in the immune system: improvement of a regulatory profile in cells from healthy children after leishmanial stimulation and down modulation of IL-10 in Treg cells and monocytes during symptomatic VL. Therefore, the use of vitamin A concomitant to VL therapy might be useful in improving recovery from disease status caused by Leishmania infantum infection and warrants additional study.

Citation: Lima Maciel BL, Valverde JG, Rodrigues-Neto JF, Freire-Neto F, Keesen TSL, Jeronimo SMB (2014) Dual Immune Modulatory Effect of Vitamin A in Human Visceral Leishmaniasis. PLoS ONE 9(9): e107564. https://doi.org/10.1371/journal.pone.0107564

Editor: Ciriaco A. Piccirillo, McGill University Health Center, Canada

Received: October 30, 2013; Accepted: August 19, 2014; Published: September 30, 2014

Copyright: © 2014 Maciel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This work has been supported by the National Institutes of Health, USA (AI-30639) and Conselho Nacional de Desenvolvimento Científico e Técnológico – CNPq, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Leishmania infantum infection is endemic in Brazil and can evolve with a large spectrum of clinical outcomes, ranging from asymptomatic, self-healing infection, to disease, visceral leishmaniasis (VL). Symptomatic VL is characterized by fever, hepatosplenomegaly, hypergammaglobulinemia, weight loss and susceptibility to other infections such as viral, bacterial or fungi, with about 5–10% of mortality, even with treatment [1], [2]. The determinants of Leishmania infection outcomes, either disease or self-resolution of the infection are not clearly understood, but could be influenced by interactions of the parasite and the immune response of the host and by environmental factors such as comorbidities [3] and nutritional status [4]–[6].

Although interferon-gamma (IFN-γ) has been found in blood and bone marrow [7], [8] of VL patients, classically symptomatic VL has been characterized by failure of peripheral blood mononuclear cells to proliferate or to produce IFN-γ in response to Leishmania antigens. In addition, VL patients present skin anergy to intradermal leishmanial antigens, which is usually reversed months after clinical cure [9]–[11]. Consistently, interleukin-10 (IL-10) production, is considered a hallmark of symptomatic VL [10], [12]–[14]. Studies have demonstrated that macrophages may be important sources of IL-10 during VL [15], [16]. Recently, regulatory T (Treg) cells have been implicated in IL-10 production and CD4+ suppression in visceral leishmaniasis [13], [17]–[19]. In human VL, Nylén et al. [13] found CD4+CD25−Foxp3− Tr1 cells as the major source of IL-10. However, Rai et al. [18] showed enrichment of IL-10 in CD4+CD25+Foxp3+ cells isolated from bone marrow of human VL cases. In addition, TGF-β, which produced by Treg cells, is important during VL. Gantt et al. [20] found high levels of TGF-β in bone marrows of VL patients, and showed that TGF-β had deactivating effect on macrophage function, both in vitro and in vivo [21].

Although much has been studied to understand the human immune response against Leishmania infection, little is known about the determinants of the immune responses during the disease. In addition to the complex interactions between the parasite and the human immune response [22], [23], other variables such as nutritional status might influence the outcome of Leishmania infection [24], [25]. It is known that chronic infections slowly deplete serum retinol, which leads to reduced immunity and increased susceptibility to further infections, as viral, bacterial or fungal, in a poorly understood cyclical relationship, which could be a risk factor for VL development [26], [27]. Although we [6] and others [6], [28] have found vitamin A deficiency in VL patients, the mechanism by which vitamin A influences the immune response to an intracellular pathogen, as Leishmania, is not understood. Studies have consistently demonstrated that all-trans retinoic acid, the main active vitamin A metabolite in the cells, enhances TGF-β induction of Foxp3 in Treg cells [29]–[31]. Intriguingly, vitamin A deficiency in mice seems to be associated with elevated IL-10 competent Treg cells [32].

Experimental immunization studies have also shown that all-trans retinoic acid promotes antibody responses to T cell-dependent antigens [33], [34]. A mice model has shown that vitamin A deficiency enhances the development of IL-10 Th2 secreting cells and reduces Th1 development [35]. All-trans retinoic acid can suppress Th17 development [31] by increasing TGF-β signaling and reducing the expression of the IL-6 receptor [36].

Although large cohort trials have shown that vitamin A supplementation decreases global mortality by 30% [37], most of the work attempting to understand the effect of vitamin A on specific T cells subsets is experimental, and its mechanisms of action remain poorly understood. Moreover, there are few published data in animal models or in human Leishmania infections linking the role of vitamin A in the immune response to the parasite [38], although vitamin A deficiency is prevalent in areas endemic for VL [6] and some of these areas tend to adopt the World Health Organization's protocol for vitamin A supplementation [39].

This study aimed to analyze the effect of vitamin A in the response against Leishmania infection in a subset of Treg cells and monocytes isolated from children with symptomatic VL, prior to treatment, and from healthy children potentially exposed to L. infantum by virtue of sharing the same environment of a VL case. We found increased IL-10 production by CD4+CD25highFoxp3+ T cells, IL-10 and TGF-β production by CD4+CD25−Foxp3− T cells and IL-10 by monocytes isolated from healthy children after in vitro all-trans retinoic acid stimulus. Interestingly, the combination of all-trans retinoic acid and leishmanial antigens in vitro prevented increases in IL-10 production in Treg cells and monocytes isolated from VL children, indicating a potential immune modulatory effect of vitamin A during L. infantum infection.

Materials and Methods

Study groups, inclusion and exclusion criteria

Subjects were recruited from an open cohort of subjects residing in a L. infantum endemic area of Northeast Brazil, as previously described [40] and also subjects under treatment for VL from July 2009 to December 2012. These later cases were from the same neighborhood described previously [40]. Twenty-six children were recruited for the present study. Children were grouped as follows: 1) Children with symptomatic visceral leishmaniasis (VL) prior to treatment (n = 10), and 2) Healthy children with no apparent signs of L. infantum infection, but residing in the endemic area and having a relative with visceral leishmaniasis (n = 16). Symptomatic VL cases were recruited in the hospital, whereas the healthy children were enrolled at their household, during a follow up visit after the VL subject was discharged from the hospital.

Inclusion criteria for each group were as follows:

1. Active VL: children with current, prior to treatment, symptomatic VL, with the diagnosis of disease status confirmed by presence of Leishmania in bone marrow aspirates and/or positive rK39. The clinical and laboratorial criteria for symptomatic disease were defined as intermittent fever for more than 3 weeks, hepatomegaly and/or splenomegaly, hypergammaglobulinemia, pancitopenia, low platelets, hematocrit and hemoglobin levels. Hemogram analyzes were done 0–1 day before immunological assessment in referral hospitals;

2. Healthy children with no apparent signs of L. infantum infection (Endemic controls): children with negative skin delayed type hypersensitivity (DTH-), Montenegro skin test, and negative anti-Leishmania antibodies, who were a contact of a VL case. Leishmania antigens were a water-soluble fraction of promastigote cultures obtained from an isolate of a human subject with VL (Leishmania infantum, IOC 3052). The skin test was placed after blood sample collection. rk39 was used to determine presence of antibodies against Leishmania [41]. Hemogram analyses and clinical evaluation were performed in this group and they presented no alterations indicative of diseases. In addition, those children presented no clinical signs of other infections such as diarrhea, coughing or fever.

Ethical considerations

The study protocol and informed consents were reviewed and approved by the Federal University of Rio Grande do Norte Ethical Committee. The certificate of ethical approval is CAAE 0087.0.051.000-09 and is available at the http://aplicacao.saude.gov.br/plataformabrasil/login.jsf. The consent form was signed by a parent or a legal guardian of the participants.

Determination of Leishmania infection

Two ELISA assays using soluble lysate antigens (SLA) and rK39 protein as source of antigens were used, as previously described [41]. Briefly, wells of ELISA plates (Costar) were coated with 200 ng of soluble Leishmania antigens (SLA) or 50 ng of rK39. The SLA was obtained from Leishmania infantum promastigote grown in culture. Leishmania isolate was obtained from a bone marrow aspirate of a human subject with symptomatic VL. The isolate was shown to be L. infantum by isoenzymes. Each serum sample was assayed in triplicate. Each plate included negative control sera from unexposed Brazilians and positive control sera from patients with documented VL. The A405 was determined using a Titertek Multiskan ICN - plate reader. The cut-off was the mean plus 3 standard deviations absorbance of negative control sera. The cut off values for the antibodies were established from the analysis of 32 blood samples collected from individuals not exposed to the endemic area.

Montenegro skin test was performed using 25 µg of Leishmania amazonensis proteins (Centro de Produção e Pesquisa de Imunobiológicos, Secretaria de Saúde, Paraná, Brazil) injected intradermally. Skin tests were read after 48–72 h, measured in two perpendicular directions using the ball-point pen method [42]. A positive test result was defined if the mean of the two induration measurements was greater than 5 mm [43].

Serum retinol determination

Serum retinol was determined by high pressure liquid chromatography (HPLC) by a modified procedure, using fasting serum samples [44]. Briefly, 500 µL of ethanol 95% containing 1 µg/mL of retinyl acetate as internal standard was added to 400 µL of sera for protein precipitation. Samples were washed, three times, with 500 µL of hexane (Merck, São Paulo, Brazil). In each time, the hexane phase was collected into a new test tube. These hexane layers were evaporated under nitrogen gas at 37°C. The resulting extracts were ressuspended in 70 µL of methanol (Merck, HPLC grade) and 20 µL was injected in the HPLC system. Mobile phase was a 100% methanol at a 1.0 mL/min flow and detection was at 325 nm. A reverse phase C18 Microsorb MV column, with 4.6×150 mm, 100 Å pore and a MPLC NewGuard Holder complete C18 (reverse phase), 3,2×15 mm guard column were used.

Peripheral blood mononuclear cells separation and culture

Peripheral blood mononuclear cells (PBMC) were isolated from heparinized venous blood after centrifugation over a Ficoll-Paque Plus gradient (GE Health Care Life Sciences). PBMC were suspended in RPMI-1640 (Sigma-Aldrich) supplemented with 10% of inactivated autologous sera, in presence of antibiotics (penicillin 200 U/mL and streptomycin, 0.1 mg/mL) and maintained in 96-well plates, 2.5×105 cells in 200 µL, per well, for 20 h at 37°C and 5% CO2. Five different conditions were used in the cultures as follows: media alone, SLA (10 µg/mL), all-trans retinoic acid (0.25 nM), SLA (10 µg/mL) + all-trans retinoic acid (0.25 nM) and concanavalin A – ConA (10 µg/mL). All-trans retinoic acid concentration was determined by titration under same culture conditions, with cells stained for anexin V and Propidium Iodide (PI) and then analyzed by flow cytometry. The concentration of 0.25 nM was chosen for the best FSC and SSC PBMC profile and low anexin V and PI staining.

Cell staining and Flow cytometry analyses

During the last 6 h of culture, brefeldin A (1 µg/mL) (eBioscience) was added to improve cytokine detection. The cells were then washed and stained for surface markers, and fixed using 2% formaldehyde (Sigma-Aldrich). Fixed cells were permeabilized and stained using anticytokine monoclonal antibodies. Immunoglobulin control antibodies and a control of unstimulated PBMC were included in all experiments [45].

Monoclonal antibodies directly conjugated with fluorocromes were: anti-CD4 APC-Cy7 (BD Biosciences), CD25 PE-Cy7 (eBioscience), CD14 PerCP (eBioscience), Foxp3 Alexa fluor 488 (BD Biosciences), TGF- β1 PerCP (R & D Systems), IL-10 APC (BD Biosciences) and IL-17F PE (eBioscience).

Preparations were acquired on BD FACSCanto II (BD Biosciences) and 30,000 events were acquired for the analysis. Data was processed using FlowJo software, version 7.6.5 (Tree Star Inc, Ashland, OR, USA). Specific gating strategies to select Treg CD4+CD25highFoxp3+, CD4+CD25−Foxp3− and monocytes (CD14+) subsets are presented through representative density plots which are shown in Figure 1. Treg cells were stained and analyzed for TGF-β1, IL-10 and IL-17, while monocytes were stained for IL-10.

thumbnail
Download:
Figure 1. Representative graphs of Treg cells and monocytes.

A. Flow cytometry dot plots represent lymphocytes region (P1), frequency of CD4+CD25highFoxp3+ T cells and cytokine analysis in these cells (TGF-β1 shown as example). B. Flow cytometry dot plots represent lymphocytes region (P1), frequency of CD4+CD25−Foxp3− T cells and cytokine analysis in these cells (IL-17 shown as example). C. Flow cytometry dot plots represent monocytes region (P2), and IL-10 analyzed in CD14+ monocytes. Graphs are examples of 20 h cultures of PBMC without any stimulus.

https://doi.org/10.1371/journal.pone.0107564.g001

Statistical analysis

Kolmogorov-Smirnov test was used to determine the normality of all the variables in study. To detect differences within the groups for age and retinol Mann-Whitney Test was used and these variables are presented as median (interquartile range – IQR). To determine whether serum retinol was associated with cytokine production in different cell subsets after SLA stimulus correlation analysis was done using Spearman correlation coefficient (r2). Mann-Whitney test was used to determine whether there were differences in Foxp3 and cytokine production, in culture, under different stimuli between endemic controls to VL subjects; or Wilcoxon matched pairs test to compare cultures stimulated and non-stimulated within studied groups. A significant difference was accepted when the p value was less than 0.05. Statistical analysis was performed using the GraphPad Prism software, version 5.

Results

Patients with symptomatic visceral leishmaniasis present low serum retinol

Of the 26 children studied, 10 had active VL, prior to treatment; and 16 were healthy children, but a household contact of a VL case. These latter children were both negative for anti-Leishmanial antibodies and Montenegro skin test [median induration (IQR) 0.0 (0.0) mm]. All children with VL had parasitological confirmation of Leishmania through a positive bone marrow aspirate and they also had positive anti-Leishmania antibodies. The two groups were homogenous, with similar age and gender distribution (p>0.05) (Table 1). Vitamin A status was significantly lower (Mann-Whitney test, p = 0.013) in children with symptomatic VL (Table 1), with median serum retinol of 20.34 (13.17) µg/dL in the VL group and 25.69 (3.97) µg/dL in the endemic control group (Table 1).

thumbnail
Download:
Table 1. Characteristics of the studied groups by age, gender, anti-Leishmania antibodies, Montenegro skin test response and serum retinol concentrations.

https://doi.org/10.1371/journal.pone.0107564.t001

Serum retinol inversely correlated with IL-10 and TGF-β1 in CD4+CD25highFoxp3+ T cells

Since CD4+CD25−Foxp3− T cells, CD4+CD25highFoxp3+ T cells and monocytes have been shown to be important source of IL-10 in VL [9], [12], [14], we evaluated whether these cells function change with respect to the serological level of vitamin A. As shown in Figure 2A, we found a significant negative correlation between serum retinol and IL-10 production in CD4+CD25highFoxp3+ T cells after SLA stimuli (Spearman, r = −0.434, p = 0.0386). We also found a significant negative correlation between serum retinol and TGF-β1 production in CD4+CD25highFoxp3+ T cells (Spearman, r = −0.507, p = 0.0190, Figure 2B).

thumbnail
Download:
Figure 2. Negative correlation between serum retinol and IL-10 and TGF-β1 production by CD4+CD25highFoxp3+ T cells.

A. Represents a negative correlation between serum retinol and IL-10 production in CD4+CD25highFoxp3+ T cells after SLA stimulus. B. Represents a negative correlation between serum retinol and TGF-β1 production in CD4+CD25highFoxp3+ T cells after SLA stimulus. Correlation analyzes were performed in VL cases (n = 10) and endemic controls (n = 16), using Spearman correlation coefficient.

https://doi.org/10.1371/journal.pone.0107564.g002

No significant correlation was found between serum retinol and IL-10, TGF-beta1 and IL-17 production in CD4+CD25highFoxp3+ T cells in medium (not shown, Spearman, p>0.05). No correlation was found for the same cytokines in the medium or after SLA stimulation for CD4+CD25−Foxp3− T cells and IL-10 in CD14+ cells (not shown, Spearman, p>0.05).

CD4+CD25highFoxp3+ T cells are lower in VL patients and increased by antigen and all-trans retinoic acid stimuli

Since vitamin A status inversely correlated with CD4+CD25highFoxp3+ T cells cytokine response after SLA stimulus, we further looked into whether the cytokine response of CD4+CD25highFoxp3+ T differed after different stimuli between the two groups (Figure 3). VL children presented significant lower CD4+CD25highFoxp3+ T cells when compared to endemic controls (Mann-Whitney, p = 0.011). However, overall after stimuli with all tested conditions, cells from the endemic controls and VL subjects had increased frequency of CD4+CD25highFoxp3+ T cells and there was no difference between VL patients and endemic controls (Figure 3A). This result potentially indicates that, in vivo, Leishmania antigens and vitamin A induce expansion of CD4+CD25highFoxp3+ T cells.

thumbnail
Download:
Figure 3. Cytokines expression in CD4+CD25highFoxp3+ T cells in response to different stimuli.

A. Lower frequency of CD4+CD25highFoxp3+ T cells in VL patients when compared to endemic controls and its increase after all stimuli. B. IL-10 production in CD4+CD25highFoxp3+ T cells after tested conditions. C. TGF-β1 production in CD4+CD25high Foxp3+ T cells after tested conditions. D. IL-17 in CD4+CD25high Foxp3+ T cells after tested conditions. Mann-Whitney test was used to compare endemic controls to VL patients. Wilcoxon matched pairs test was used to compare cultures stimulated and non-stimulated within the studied groups. * p<0.05; ** p <0.01. Subjects tested: endemic controls (n = 16) and VL patients (n = 10). Bars represent median and IQR. ATRA  =  all-trans retinoic acid. SLA  =  Soluble Leishmania antigens (SLA). ConA  =  Concanavalin A.

https://doi.org/10.1371/journal.pone.0107564.g003

All-trans retinoic acid induces distinct cytokine production in CD4+CD25highFoxp3+ T cells from visceral leishmaniasis subjects

CD4+CD25highFoxp3+ T from VL subjects had increased IL-10 production after SLA stimulation, whereas endemic controls had not (Figure 3B). Interestingly, all-trans retinoic acid significantly increased IL-10 in cells isolated from the endemic controls, but the same effect was not observed in VL subjects. However, all-trans retinoic acid used in combination with SLA abrogated the effect of IL10 production in CD4+CD25highFoxp3+ T isolated from VL subjects (Figure 3B). However, for endemic controls, all-trans retinoic acid + SLA stimulated IL-10 production. Similarly, all-trans retinoic acid significantly induced TGF-β1 in CD4+CD25highFoxp3+ T cells isolated from the endemic controls (Wilcoxon,  = 0.037), but not for VL subjects (Figure 3C). CD4+CD25highFoxp3+ T cells from controls after SLA stimulation had significantly more IL-17 production (Wilcoxon, p = 0.009), but not in CD4+CD25highFoxp3+ cells from VL subjects (Figure 3D). All-trans retinoic acid whether alone or in combination with SLA produced no effect on IL-17 production in CD4+CD25highFoxp3+ T cells from VL patients or endemic controls (Figure 3D). The cytokine response observed after all-trans retinoic acid or SLA stimulation in CD4+CD25highFoxp3+ is more likely driven by specific antigens in the SLA preparation and all-trans retinoic acid, as can be observed by comparison of the response to all-trans retinoic acid and SLA with Concanavalin A.

All-trans retinoic acid decreases IL-17 production by CD4+CD25−Foxp3− T cells from VL subjects

CD4+CD25−Foxp3− T cells frequency was similar between the studied groups (Figure 4A), but cells isolated from VL patients responded to SLA stimulation with significantly more IL-10 production (Figure 4B). After all-trans retinoic acid stimulation, an increase in IL-10 production by CD4+CD25−Foxp3− T cells was seen only in cells isolated from endemic controls, in presence or absence of SLA stimuli (Figure 4B). However, CD4+CD25−Foxp3− did not increase the production of TGF-β1 in response to any of stimuli tested (Figure 4C). Surprisingly, CD4+CD25−Foxp3− T cells isolated from VL subjects showed lower production of TGF- β1 when compared to endemic controls (Figure 4C).

thumbnail
Download:
Figure 4. Cytokines expression in of CD4+CD25−Foxp3− response to different stimuli.

A. Similar frequency of CD4+CD25−Foxp3− T cells in studied groups and conditions. B. IL-10 production in CD4+CD25−Foxp3− T cells after tested conditions. C.TGF-β1 production in CD4+CD25−Foxp3− T cells after tested conditions. D. IL-17 production in CD4+CD25−Foxp3− T cells after tested conditions. Subjects tested, endemic controls (n = 16) and VL patients (n = 10). Mann-Whitney test was used to compare endemic controls to VL patients. Wilcoxon matched pairs test was used to compare cultures stimulated and non-stimulated within the studied groups. * p<0.05; ** p<0.01. Bars represent median and IQR. ATRA  =  all-trans retinoic acid. SLA  =  Soluble Leishmania antigens (SLA). ConA  =  Concanavalin A.

https://doi.org/10.1371/journal.pone.0107564.g004

It was interesting to note that after SLA stimulation CD4+CD25−Foxp3− T cells of endemic controls significantly increased IL-17 production (Wilcoxon, p = 0.013), but not cells from VL subjects (Figure 4D). All-trans retinoic acid reduced IL-17 production in cells from VL (Wilcoxon, p = 0.039). No effect was seen when adding all-trans retinoic acid + SLA in IL-17 production by cells from cases or controls (Figure 4D).

All-trans retinoic acid prevented the increase in IL-10 produced by monocyte from VL subjects

We further analyzed the effect of the different stimuli on IL-10 production in monocytes. There was a decrease in the frequency of CD14+ monocytes in VL subjects (Figure 5A). Moreover, subjects with VL produced significantly higher amounts of IL-10 after SLA stimulus when compared to endemic controls (Mann-Whitney, p = 0.002) or to the medium (Wilcoxon, p = 0.023) (Figure 5B). Interestingly, all-trans retinoic acid significantly increased IL-10 production in endemic controls, but the same effect was not observed in VL patients. Once more, the use of all-trans retinoic acid + SLA in VL patients prevented the increase of IL-10 seen after SLA stimulation alone (Figure 5B). However, for endemic controls, all-trans retinoic acid + SLA stimulated IL-10 production.

thumbnail
Download:
Figure 5. IL-10 expression in CD14+ monocytes after different stimuli.

A. Significant reduced frequency of CD14+ monocytes in VL patients. B. IL-10 production in CD14+ monocytes after tested conditions Mann-Whitney test was used to compare endemic controls to VL patients. Wilcoxon matched pairs test was used to compare cultures stimulated and non-stimulated within the studied groups. * p<0.05; ** p<0.01. Bars represent median and IQR. ATRA  =  all-trans retinoic acid. SLA  =  Soluble Leishmania antigens (SLA). ConA  =  Concanavalin A.

https://doi.org/10.1371/journal.pone.0107564.g005

Discussion

Nutrients can influence the immune response [46], [47] and the immune response itself can act synergistically in response to drug treatment during diseases, improving recovery [48]. Therefore, the efficacy of drug therapy could potentially be improved, if used in combination with immunostimulants [49], [50]. Experimental models in VL have shown that antagonizing the effect of IL-10 dramatically enhanced the leishmanial activity of Sbv [51], [52]. Nevertheless, few studies have attempted to use nutrients as immune modulators in VL, although it is well documented that malnutrition increases the risk of developing visceral leishmaniasis [1], [5]. In this study, we showed a correlation of vitamin A status and cytokines in response to Leishmania infection. Moreover, we observed a dual effect of vitamin A: in healthy children, it induced a regulatory profile and in subjects with VL it prevented IL-10 increase after stimulation with leishmanial antigens.

Impaired vitamin A status is a characteristic of VL, previously shown by us [6] and others [28]. Our previous study showed, that the low concentrations of serum retinol in VL were not uniquely related to the acute stress response in Leishmania infections [6]. To our knowledge, this is the first study in human VL that finds a negative correlation between serum retinol and key cytokines to this disease such as IL-10 and TGF-β (Figure 2). This reinforces the importance of vitamin A as regulatory factor in the immune response that might influence the outcome of Leishmania infections.

Stephensen et al. [35] also observed that vitamin A deficiency was associated with enhanced development of IL-10 producing T cells. In that study, they were not able to detect whether these cells were Th2 or Treg cells. Nevertheless, the study from Maynard et al. [32] found that, during vitamin A deficiency, C57BL/6 mice had increased numbers of competent IL-10 producing Treg cells. Taken together, these results indicate that during vitamin A deficiency Treg cells may be important subsets in IL-10 production. In our study, SLA alone enhanced IL-10 production in cells isolated from VL subjects, which is in accordance to the studies of Rai et al. [18] and Nylén et al. [13] that found high production of IL-10 in nTreg, Tr1 and monocytes, respectively after Leishmania antigen stimulation. However, no significant IL-10 production was observed when all-trans retinoic acid and SLA were added. Intriguingly, in cells isolated from the endemic controls, the use of all-trans retinoic acid in combination with SLA enhanced IL-10 and TGF-β1 production in CD4+CD25−Foxp3− T cells and IL-10 in monocytes. These results might indicate a regulatory role for vitamin A in Leishmania infection. Prior studies have exploited this regulatory role of vitamin A, in auto-immune disorders [53], [54].

The role of Treg cells in leishmaniasis remains controversial, although they seem to be important cells in T CD4+ suppression during VL [18]. Despite the ability of Treg cells to suppress excessive immune response against the Leishmania, most of the studies have shown that these cells may promote an excessive regulatory control which allows parasite replication, survival and long term persistence [55]–[58]. Surprisingly, our data clearly demonstrates that Treg cells and monocytes isolated from VL patients have different responses when stimulated with all-trans retinoic acid comparing to healthy controls. These results indicate a defect in cell function during L. infantum infection. One possibility to explain the lack of response after all-trans retinoic acid stimulus in VL is cell exhaustion and this has been successfully demonstrated in T CD8+ cells in some studies during VL [59], [60]. In this study, the use of all-trans retinoic acid together with leishmanial antigens in vitro prevented increases in IL-10 production in Treg cells and monocytes isolated from VL children. Our results illustrate the effects of a single vitamin A metabolite in the balance of the immune response.

Moreover, we found low CD4+CD25highFoxp3+ T cells in PBMC, and this corroborated the finding of Nylén et al. in Indian VL [13]. This result may indicate that there is not a failure in the expansion of CD4+CD25highFoxp3+ T cells during VL, but possibly a differential homing of these cells to the sites of infection. Nylén et al. [13] saw no increase of these cells in the spleen of humans with VL, but Rai et al. [18] observed enrichment of these cells in the bone marrow of subjects with disease.

Interestingly, cells from endemic control showed pronounced IL-17 production after SLA stimulus in CD4+CD25highFoxp3+ and CD4+CD25−Foxp3− T cells while VL subjects did not. Our data corroborates the results from Pitta et al. [62] who found an increased production of IL-17 in PBMC of healthy individuals after L. donovani stimulus, signalizing that this cytokine plays a role in the protective response against Leishmania infection [61]. However, CD4+CD25−Foxp3− T cells from VL significantly decreased IL-17 production after all-trans retinoic acid stimulus. Nevertheless, our results of all-trans retinoic acid reducing the production of IL-17 and stimulating CD4+CD25highFoxp3+ T cell expansion are in accordance to studies which have shown that retinoic acid can stimulate Treg conversion and reduce Th17 conversion in the presence of TGF-β [30], [31], [36], [63]–[65].

All-trans retinoic acid effect on cells seems to be dose-dependent. Dawson et al. [66] observed that increasing doses of all-trans retinoic acid (1, 10 and 100 nM) led to increased IL-5, IL-4 production and decreased IFN-γ by PBMCs. Elias et al. [63], observed that in even higher doses of all-trans retinoic acid (1 nM, 100 nM and 10 µM) progressively decreased IL-17 production and increased Foxp3 expression in T cells isolated from mice spleen and lymph nodes. A problem in analyzing the effect of different all-trans retinoic acid concentrations used in these studies is that in none of them, cell viability or cell death data were observed after culture with the different all-trans retinoic acid concentrations. Nevertheless, the results from these studies show that all-trans retinoic acid effect was more likely linear, once inversion in its effect with increasing doses was not observed.

It has been extensively shown that PBMC from VL patients lack the ability to produce IFN-γ in response to Leishmania antigen stimulation [9]–[11], although increased amounts of IFN-γ are found in whole blood cell assays from VL patients [7], [8]. Moreover, it is well known that all-trans retinoic acid inhibits IFN-γ gene expression possibly by directly acting on its promoter [66], [67]. In our study, IFN-γ was not analyzed, but subjects had a skin test negative.

Studies in Leishmania and other infections have shown that there may be differences in the innate immune responses between males and females [68]–[71]. In addition, there is an increased risk of developing visceral leishmaniasis after age 10 among males, although there is no difference between the rate of L. infantum infection between males and females residing in urban endemic area for VL (Monteiro et al, unpublished results). In this study, we only analyzed cells isolated from children and there was no difference in gender distribution among the study subjects. Therefore the question of the impact of gender in the inate immunity needs different design, considering age and sex differences. Surprisingly, our study has found lower levels of TGF-β1 production in CD4+CD25−Foxp3− T cells of VL patients when compared to endemic controls. This result may be explained by the cell population analyzed, which may not represent the main TGF-β1 producers during VL. Although it is known that TGF- β is high in VL [20], few studies have identified the source of this cytokine production.

Not many studies have addressed the role of nutrients on Leishmania infection. Garg et al. [38] in a model of hamsters infected with L. donovani observed that vitamin A supplements given prophylactically or after infection promoted increased parasite burden. Conversely, our study showed that all-trans retinoic acid increased IL-10 and TGF-β1 in Treg and IL-10 in monocytes isolated from healthy children. However, all-trans retinoic acid plus Leishmania antigens stimulation prevented the increased production of IL-10 after SLA stimulus by cells isolated from children with VL, which may indicate a potential modulatory effect of all-trans retinoic acid in cytokine associated to disease.

In summary, our results show that Treg cells and monocytes during VL have different responses to stimuli when compared to cells from healthy controls, indicating an important role of these cells during the disease. Furthermore, we show that vitamin A may present a dual role in the immune response regulation: improvement of regulatory responses in healthy children exposed to Leishmania antigens and down modulation of IL-10 expression in Treg and monocytes during VL. Therefore, the use of vitamin A concomitant to VL therapy needs to be evaluated in further studies. Finally, this study reinforces the importance of vitamin A, a single nutrient that comes from the diet, which is a modifiable risk factor, in the immune response to Leishmania infection.

Acknowledgments

This work was supported by the National Institutes of Health, USA (AI-30639) and by Conselho Nacional de Desenvolvimento Científico e Técnológico – CNPq, Brazil. We thank Mr. Manoel Gomes Fernandes (Fundação Nacional de Saúde) for assistance during field work. We also thank Dr Roberto Dimenstein (Biochemistry Department, Federal University of Rio Grande do Norte - UFRN) and Dr. Goreti Macedo (Biochemistry Engineering Department, UFRN) for their support in the quantification of Vitamin A.

Author Contributions

Conceived and designed the experiments: BLLM SMBJ. Performed the experiments: BLLM JGV JFRN FFN TSLK SMBJ. Analyzed the data: BLLM JGV TSLK SMBJ. Contributed reagents/materials/analysis tools: BLLM SMBJ. Wrote the paper: BLLM SMBJ.

References

  1. 1. Badaro R, Jones TC, Lorenco R, Cerf BJ, Sampaio D, et al. (1986) A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 154: 639–649.
  2. 2. Evans TG, Teixeira MJ, McAuliffe IT, Vasconcelos I, Vasconcelos AW, et al. (1992) Epidemiology of visceral leishmaniasis in northeast Brazil. J Infect Dis 166: 1124–1132.
  3. 3. Wilson ME, Jeronimo SM, Pearson RD (2005) Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog 38: 147–160.
  4. 4. Cerf BJ, Jones TC, Badaro R, Sampaio D, Teixeira R, et al. (1987) Malnutrition as a risk factor for severe visceral leishmaniasis. J Infect Dis 156: 1030–1033.
  5. 5. Harrison LH, Naidu TG, Drew JS, de Alencar JE, Pearson RD (1986) Reciprocal relationships between undernutrition and the parasitic disease visceral leishmaniasis. Rev Infect Dis 8: 447–453.
  6. 6. Maciel BL, Lacerda HG, Queiroz JW, Galvao J, Pontes NN, et al. (2008) Association of nutritional status with the response to infection with Leishmania chagasi. Am J Trop Med Hyg 79: 591–598.
  7. 7. Karp CL, el-Safi SH, Wynn TA, Satti MM, Kordofani AM, et al. (1993) In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest 91: 1644–1648.
  8. 8. Singh OP, Gidwani K, Kumar R, Nylen S, Jones SL, et al. (2012) Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin Vaccine Immunol 19: 961–966.
  9. 9. Bacellar O, Brodskyn C, Guerreiro J, Barral-Netto M, Costa CH, et al. (1996) Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis. J Infect Dis 173: 1515–1518.
  10. 10. Caldas A, Favali C, Aquino D, Vinhas V, van WJ, et al. (2005) Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect Dis 5: 113–122.
  11. 11. Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson WD Jr (1985) Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 76: 2066–2069.
  12. 12. Kenney RT, Sacks DL, Gam AA, Murray HW, Sundar S (1998) Splenic cytokine responses in Indian kala-azar before and after treatment. J Infect Dis 177: 815–818.
  13. 13. Nylen S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, et al. (2007) Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204: 805–817.
  14. 14. Sacks DL, Lal SL, Shrivastava SN, Blackwell J, Neva FA (1987) An analysis of T cell responsiveness in Indian kala-azar. J Immunol 138: 908–913.
  15. 15. Kane MM, Mosser DM (2001) The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166: 1141–1147.
  16. 16. Miles SA, Conrad SM, Alves RG, Jeronimo SM, Mosser DM (2005) A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med 201: 747–754.
  17. 17. Ganguly S, Mukhopadhyay D, Das NK, Chaduvula M, Sadhu S, et al. (2010) Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis. J Invest Dermatol 130: 1013–1022.
  18. 18. Rai AK, Thakur CP, Singh A, Seth T, Srivastava SK, et al. (2012) Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis. PLoS One 7: e31551.
  19. 19. Rodrigues OR, Marques C, Soares-Clemente M, Ferronha MH, Santos-Gomes GM (2009) Identification of regulatory T cells during experimental Leishmania infantum infection. Immunobiology 214: 101–111.
  20. 20. Gantt KR, Schultz-Cherry S, Rodriguez N, Jeronimo SM, Nascimento ET, et al. (2003) Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages. J Immunol 170: 2613–2620.
  21. 21. Barral-Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth LR, et al. (1992) Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 257: 545–548.
  22. 22. Jamieson SE, Miller EN, Peacock CS, Fakiola M, Wilson ME, et al. (2007) Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil. Genes Immun 8: 84–90.
  23. 23. Jeronimo SM, Duggal P, Ettinger NA, Nascimento ET, Monteiro GR, et al. (2007) Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan. J Infect Dis 196: 1261–1269.
  24. 24. Anstead GM, Chandrasekar B, Zhao W, Yang J, Perez LE, et al. (2001) Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect Immun 69: 4709–4718.
  25. 25. Davies CR, Mazloumi Gavgani AS (1999) Age, acquired immunity and the risk of visceral leishmaniasis: a prospective study in Iran. Parasitology 119 (Pt 3): 247–257.
  26. 26. Cantorna MT, Nashold FE, Chun TY, Hayes CE (1996) Vitamin A down-regulation of IFN-gamma synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway. J Immunol 156: 2674–2679.
  27. 27. Thurnham DI, McCabe GP, Northrop-Clewes CA, Nestel P (2003) Effects of subclinical infection on plasma retinol concentrations and assessment of prevalence of vitamin A deficiency: meta-analysis. Lancet 362: 2052–2058.
  28. 28. Bern C, Haque R, Chowdhury R, Ali M, Kurkjian KM, et al. (2007) The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village. Am J Trop Med Hyg 76: 909–914.
  29. 29. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ (2007) All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204: 1765–1774.
  30. 30. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256–260.
  31. 31. Nolting J, Daniel C, Reuter S, Stuelten C, Li P, et al. (2009) Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J Exp Med 206: 2131–2139.
  32. 32. Maynard CL, Hatton RD, Helms WS, Oliver JR, Stephensen CB, et al. (2009) Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells. J Exp Med 206: 343–357.
  33. 33. Pasatiempo AM, Kinoshita M, Taylor CE, Ross AC (1990) Antibody production in vitamin A-depleted rats is impaired after immunization with bacterial polysaccharide or protein antigens. FASEB J 4: 2518–2527.
  34. 34. Sankaranarayanan S, Ma Y, Bryson MC, Li NQ, Ross AC (2007) Neonatal-age treatment with vitamin A delays postweaning vitamin A deficiency and increases the antibody response to T-cell dependent antigens in young adult rats fed a vitamin A-deficient diet. J Nutr 137: 1229–1235.
  35. 35. Stephensen CB, Jiang X, Freytag T (2004) Vitamin A deficiency increases the in vivo development of IL-10-positive Th2 cells and decreases development of Th1 cells in mice. J Nutr 134: 2660–2666.
  36. 36. Xiao S, Jin H, Korn T, Liu SM, Oukka M, et al. (2008) Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181: 2277–2284.
  37. 37. Glasziou PP, Mackerras DE (1993) Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 306: 366–370.
  38. 38. Garg R, Singh N, Dube A (2004) Intake of nutrient supplements affects multiplication of Leishmania donovani in hamsters. Parasitology 129: 685–691.
  39. 39. World Health Organization, UNICEF (1997) Vitamin A supplements: a guide to their use in the treatment and prevention of vitamin A deficiency and xerophthalmia. Geneva, World Health Organization.
    • 40. Jeronimo SM, Duggal P, Braz RF, Cheng C, Monteiro GR, et al. (2004) An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil. Scand J Infect Dis 36: 443–449.
    • 41. Braz RF, Nascimento ET, Martins DR, Wilson ME, Pearson RD, et al. (2002) The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection. Am J Trop Med Hyg 67: 344–348.
    • 42. Sokal JE (1975) Editorial: Measurement of delayed skin-test responses. N Engl J Med 293: 501–502.
    • 43. Montenegro J (1926) Cutaneous reaction in leishmaniasis. Archives Dermatol Syphilis 13: 187–194.
    • 44. Mayne ST, Cartmel B, Silva F, Kim CS, Fallon BG, et al. (1998) Effect of supplemental beta-carotene on plasma concentrations of carotenoids, retinol, and alpha-tocopherol in humans. Am J Clin Nutr 68: 642–647.
    • 45. Bottrel RL, Dutra WO, Martins FA, Gontijo B, Carvalho E, et al. (2001) Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun 69: 3232–3239.
    • 46. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI (2011) Human nutrition, the gut microbiome and the immune system. Nature 474: 327–336.
    • 47. Maggini S, Wintergerst ES, Beveridge S, Hornig DH (2007) Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr 98 Suppl 1S29–S35.
    • 48. Doenhoff MJ, Modha J, Lambertucci JR, McLaren DJ (1991) The immune dependence of chemotherapy. Parasitol Today 7: 16–18.
    • 49. Adinolfi LE, Bonventre PF, Vander PM, Eppstein DA (1985) Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Infect Immun 48: 409–416.
    • 50. Haidaris CG, Bonventre PF (1983) Efficacy of combined immunostimulation and chemotherapy in experimental visceral Leishmaniasis. Am J Trop Med Hyg 32: 286–295.
    • 51. Murray HW, Flanders KC, Donaldson DD, Sypek JP, Gotwals PJ, et al. (2005) Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infect Immun 73: 3903–3911.
    • 52. Murray HW, Moreira AL, Lu CM, DeVecchio JL, Matsuhashi M, et al. (2003) Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. J Infect Dis 188: 458–464.
    • 53. Di Caro V, Phillips B, Engman C, Harnaha J, Trucco M, et al. (2013) Retinoic acid-producing, ex vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B-lymphocytes. Clin Exp Immunol 174: 302–317.
    • 54. Ma J, Liu Y, Li Y, Gu J, Liu J, et al. (2013) Differential role of all-trans retinoic acid in promoting the development of CD4+ and CD8+ regulatory T cells. J Leukoc Biol.
      • 55. Carrier Y, Yuan J, Kuchroo VK, Weiner HL (2007) Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 178: 179–185.
      • 56. Peralta L, Fragoso G, Fleury A, Sciutto E (2011) Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections. Int J Biol Sci 7: 1412–1426.
      • 57. Nylen S, Gautam S (2010) Immunological perspectives of leishmaniasis. J Glob Infect Dis 2: 135–146.
      • 58. Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490–500.
      • 59. Gautam S, Kumar R, Singh N, Singh AK, Rai M, et al. (2013) CD8 T Cell Exhaustion in Human Visceral Leishmaniasis. J Infect Dis 209: 290–299.
      • 60. Joshi T, Rodriguez S, Perovic V, Cockburn IA, Stager S (2009) B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections. PLoS Pathog 5: e1000431.
      • 61. Xu L, Kitani A, Fuss I, Strober W (2007) Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 178: 6725–6729.
      • 62. Pitta MG, Romano A, Cabantous S, Henri S, Hammad A, et al. (2009) IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest 119: 2379–2387.
      • 63. Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, et al. (2008) Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111: 1013–1020.
      • 64. Weaver CT, Hatton RD (2009) Interplay between the TH17 and TReg cell lineages: a (co-) evolutionary perspective. Nat Rev Immunol 9: 883–889.
      • 65. Ziegler SF, Buckner JH (2009) FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect 11: 594–598.
      • 66. Dawson HD, Collins G, Pyle R, Key M, Weeraratna A, et al. (2006) Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol 7: 27–42.
      • 67. Cippitelli M, Ye J, Viggiano V, Sica A, Ghosh P, et al. (1996) Retinoic acid-induced transcriptional modulation of the human interferon-gamma promoter. J Biol Chem 271: 26783–26793.
      • 68. Guerra-Silveira F, Abad-Franch F (2013) Sex bias in infectious disease epidemiology: patterns and processes. PLoS One 8: e62390.
      • 69. Liu L, Wang L, Zhao Y, Wang Y, Wang Z, et al. (2006) Testosterone attenuates p38 MAPK pathway during Leishmania donovani infection of macrophages. Parasitol Res 99: 189–193.
      • 70. Qiao Z, Guo Z, Yin G, Yin L, Zhao J, et al. (1999) Testosterone inhibits apoptosis of Leishmania donovani-infected macrophages. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 17: 21–24.
      • 71. Yin G, Guo Z, Yin L, Zhao J, Qiao Z, et al. (1998) Effect of testosterone on Leishmania donovani infection levels of murine bone marrow derived-macrophages. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 16: 251–255.